Where the $ Goes...

To date, Obliteride has raised over $9.2 million for cancer research at Fred Hutch. Cures start here, because of you.
Obltieride funds research in the areas of greatest need at Fred Hutch. From Basic Sciences and Public Health to deep exporation into organ-specific cancers and immunotherapy, we've funded over $9.2 million in research over the past four years. The areas we've been able to impact, with the dollars you've raised and/or donated, include:

LUNG CANCER


Gaining clarity in the growing prevalence of non-smoking lung cancers and deeper understanding of how genetic factors influence lung cancer appearance and treatment.
PROSTATE CANCER


Fred Hutch investigators recently published research linking BRCA mutations with prostate cancer, helping us identify those more at risk.
BRAIN CANCER


Focusing on curative therapies and improved surgical processes using 'tumor paint', to help preserve healthy tissue and function.
BREAST CANCER


Staying ahead of metastic breast cancer cells when we can't event detect them. Combined with Fred Hutch's leadership of the Women's Health Initiative, the Hutch has radically reduced the impact of breast cancer.
OVARIAN CANCER


Better detection, understanding and treatment are all critical to increasing the survivor rates.
CLINICAL RESEARCH SERVICES


Groundbreaking clinical trails advance discovery, leading to cures. Housed at Fred Hutch, CRS supports hundreds of trails annually across the Fred Hutch/University of Washington Cancer Consortium.
RURAL ENVIORNMENTAL FACTORS


Does where you live matter? Enviornmental exposure, lifestyle choices and access to healthcare and community services all impact the incidence of cancer. Obliteride is helping understand how and what we can do better.

AVOIDING INFECTION
 


Nearly 25% of cancers are caused by infection. Avoid infection, avoid some cancers. HPV vaccination (pioneered here at Fred Hutch) has the potential to eradicate nearly all cervical cancer and many head and neck cancers. We're funding more discoveries like the HPV vaccine.
SOLID TUMOR TRANSLATIONAL RESEARCH
 


Moving lab theory, data models and tissue typing from the lab to the bedside as rapidly as possible.
IMMUNOTHERAPY

 



Fred Hutch is paying the way with less invasive and less toxic cancer treatments. Accelerating this research is vital to curing cancer faster.